Advancing U.S.-based cGMP manufacturing to support clinical and future commercial objectives of a novel siRNA therapy for skin cancers Costa
Costa Mesa, California — [March 19, 2026] — Pyramid Pharma Services, a U.S.-based contract development and manufacturing organization (CDMO)
Lyophilization may be essential for biopharmaceutical products Lyophilization. Not easily pronounced, may be essential for biopharmaceutical products. In simple terms,
Innovations in Drug Delivery Manufacturing The future of autoinjectors is about more than new devices. It’s about giving patients confidence
Filling the Future with Innovation Costa Mesa, CA – September 11, 2025 – Pyramid Pharma Services proudly hosted the grand
